Window of Opportunity Trial of Neoadjuvant ADXS 11-001 Vaccination Prior to Robot -Assisted Resection of HPV-Positive Oropharyngeal Squamous Cell Carcinoma
Phase of Trial: Phase II
Latest Information Update: 27 Apr 2018
At a glance
- Drugs Axalimogene filolisbac (Primary)
- Indications Oropharyngeal cancer; Squamous cell cancer
- Focus Pharmacodynamics
- 23 Apr 2018 Status changed to recruiting.
- 26 Mar 2018 According to an Advaxis media release, data from this trial will be presented at the American Association for Cancer Research Annual Meeting 2018.
- 07 Nov 2017 Status changed from recruiting to active, no longer recruiting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History